It has been reported that conditional deletion of FoxO1, FoxO3 and FoxO4 simultaneously results in the development of hemangiomas and thymic lymphomas [55], and IκB kinase represses FoxO3a activity to promote human breast tumorigenesis and acute myeloid leukemia (AML) [52,53]. Here, FOXO4 is linked to thymus lymphoma.